A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.

Journal: Cell

Published: 2020-08-19

DOI: 10.1016/j.cell.2020.08.026

Affiliations: 10

Authors: 31

Go to article
Institutions Share
Washington University School of Medicine (WUSM), WUSTL, United States of America (USA) 0.35
Department of Pathology and Immunology, WUSTL, United States of America (USA) 0.32
UNC Department of Epidemiology, United States of America (USA) 0.11
Department of Radiation Oncology, WUSTL, United States of America (USA) 0.08
Division of Pulmonary and Critical Care Medicine, WUSTL, United States of America (USA) 0.05
Center for Infectious Disease and Vaccine Research, LJI, United States of America (USA) 0.03
Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs (CHiiPs), WUSTL, United States of America (USA) 0.03
UNC Department of Microbiology and Immunology, United States of America (USA) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER